Short answer · Medically reviewed summary · Last updated: 2026-05-08
TL;DR: The primary treatment for Maroteaux-Lamy syndrome, also known as Mucopolysaccharidosis type VI (MPS VI), is Enzyme Replacement Therapy (ERT) to replace the missing arylsulfatase B enzyme. While ERT manages systemic symptoms, a multidisciplinary approach involving surgery and physical therapy is essential to address the orthopedic and cardiac manifestations of Maroteaux-Lamy syndrome. What is the current standard of care for Maroteaux-Lamy syndrome? The cornerstone of management for Maroteaux-Lamy syndrome is weekly intravenous administration of elosulfase alfa (Vimizim).
What are the best treatments for Maroteaux-Lamy Syndrome?
Treatments for Maroteaux-Lamy Syndrome: what real patients say works for them, alongside a medically reviewed overview citing sources like NIH GARD and Orphanet.
TL;DR: The primary treatment for Maroteaux-Lamy syndrome, also known as Mucopolysaccharidosis type VI (MPS VI), is Enzyme Replacement Therapy (ERT) to replace the missing arylsulfatase B enzyme. While ERT manages systemic symptoms, a multidisciplinary approach involving surgery and physical therapy is essential to address the orthopedic and cardiac manifestations of Maroteaux-Lamy syndrome.
What is the current standard of care for Maroteaux-Lamy syndrome?
The cornerstone of management for Maroteaux-Lamy syndrome is weekly intravenous administration of elosulfase alfa (Vimizim). This enzyme replacement therapy provides the body with the functional enzyme that patients with Maroteaux-Lamy syndrome lack, which helps reduce the accumulation of glycosaminoglycans (GAGs) in tissues. Because Maroteaux-Lamy syndrome is a progressive condition, early initiation of treatment is generally recommended to stabilize pulmonary function and improve endurance.
How does a multidisciplinary team manage Maroteaux-Lamy syndrome?
Because Maroteaux-Lamy syndrome affects multiple organ systems, care must be coordinated by a team of specialists. Treatment effectiveness varies significantly based on the age of diagnosis and the severity of the genetic mutation. Common interventions include:
- Orthopedic surgery: To manage hip dysplasia, spinal cord compression, and joint contractures.
- Cardiac monitoring: Regular echocardiograms to track valvular heart disease.
- Physical and Occupational Therapy: Essential to maintain range of motion and functional independence.
- Ophthalmology: Monitoring for corneal clouding, which is a hallmark of Maroteaux-Lamy syndrome.
- Audiology: Managing chronic ear infections and hearing loss.
Are there emerging treatments for Maroteaux-Lamy syndrome?
Research into Maroteaux-Lamy syndrome is ongoing, focusing on hematopoietic stem cell transplantation (HSCT) in select cases, though this carries significant risks and is not standard for all patients. Clinical trials continue to explore gene therapy and substrate reduction therapies to improve long-term outcomes for those living with Maroteaux-Lamy syndrome.
Next steps
- Consult with a metabolic geneticist to establish a personalized care plan.
- Connect with the 3 members of the DiseaseMaps.org community who are living with this condition.
- Regularly review new clinical trial listings on ClinicalTrials.gov.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always consult your personal physician regarding your specific health needs.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Maroteaux-Lamy syndrome.
- Orphanet: Mucopolysaccharidosis type VI.
- National MPS Society: MPS VI patient resources.
- OMIM (Online Mendelian Inheritance in Man): Entry #253200.
